Chandler H. Park, MD, and Tian Zhang, MD, MHS, give an overview of renal cell carcinoma (RCC) and outline disease risk factors, symptoms, and prevention strategies. Chandler H. Park, M.D.: Hello, and ...
Scientists have taken a decisive step toward ending one of transplant medicine’s most stubborn bottlenecks: the need to match donor organs to a recipient’s blood type. By chemically reengineering a ...
• C3G and IgAN are kidney diseases where abnormal protein buildup in the kidneys’ filtering units leads to inflammation and damage, ultimately impairing kidney function. • Treatment for these ...